Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Share-based Compensation (2010 - 2019)

Kraig Biocraft Laboratories recorded quarterly Share-based Compensation of -$19915.0 in Q2 2019, down 127.44% quarter-over-quarter from $72575.0 in Q1 2018.

Kraig Biocraft Laboratories' Share-based Compensation history runs 9 years deep, the most recent figure standing at -$19915.0 for Q2 2019.

  • In Q2 2019, Share-based Compensation changed N/A year-over-year to -$19915.0; the TTM figure through Dec 2025 stood at -$19915.0 (changed N/A YoY), while the FY2025 annual figure was $834600.0, changed N/A from the prior year.
  • Share-based Compensation came in at -$19915.0 for Q2 2019 at Kraig Biocraft Laboratories, down from $72575.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $842850.0 in Q2 2017 to a low of -$19915.0 in Q2 2019.
  • A 5-year average of $406748.0 and a median of $590335.0 in 2015 frame the typical range for Share-based Compensation.
  • On a YoY basis, Share-based Compensation climbed as much as 1306.22% in 2018 and fell as far as 1306.22% in 2018.
  • Kraig Biocraft Laboratories' Share-based Compensation stood at $590335.0 in 2015, then rose by 10.8% to $654074.0 in 2016, then advanced by 28.86% to $842850.0 in 2017, then slumped by 91.39% to $72575.0 in 2018, then plunged by 127.44% to -$19915.0 in 2019.
  • According to Business Quant data, Share-based Compensation over the past three periods registered -$19915.0, $72575.0, and $842850.0 for Q2 2019, Q1 2018, and Q2 2017 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn 41.00 Mn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn -
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn 29.50 Mn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn 27.10 Mn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn 15.90 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn 11.00 Mn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn 47.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn 7.88 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn 13.00 Mn
10 Kraig Biocraft Laboratories - - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2019 -19,915.00
Jun 30, 2019 -19,915.00
Mar 31, 2018 72,575.00
Mar 31, 2018 72,575.00
Jun 30, 2017 842,850.00
Jun 30, 2017 842,850.00
Mar 31, 2017 5,161.00
Mar 31, 2017 5,161.00
Dec 31, 2016 654,074.00
Dec 31, 2016 654,074.00
Sep 30, 2016 702,156.00
Sep 30, 2016 702,156.00
Jun 30, 2015 590,335.00
Jun 30, 2015 590,335.00
Mar 31, 2014 403,540.00
Mar 31, 2014 403,540.00
Dec 31, 2012 400,000.00
Dec 31, 2012 400,000.00
Sep 30, 2012 -510,000.00
Sep 30, 2012 -510,000.00
Jun 30, 2012 510,000.00
Jun 30, 2012 510,000.00
Dec 31, 2011 312,000.00
Dec 31, 2011 312,000.00
Sep 30, 2011 -70,000.00
Sep 30, 2011 -70,000.00
Jun 30, 2011 70,000.00
Jun 30, 2011 70,000.00
Dec 31, 2010 414,000.00
Dec 31, 2010 414,000.00
Sep 30, 2010 -5,000.00
Sep 30, 2010 -5,000.00